•  
  •  
 

Acta Universitatis Lodziensis, Folia Biologica et Oecologica

Abstract

Programmed cell death (apoptosis) plays a vital role in the regulation of cellular homeostasis. Because of apoptosis fundamental importance, this process is highly regulated. One important set of factors involved in apoptosis regulation is the Bcl-2 family proteins. Bcl-2 family members form a complex regulatory network that controls cell survival and death in response to different physiological and pathological signals. This family includes both pro- and anti-apoptotic members, and Bax protein (Mol wt 21 kDa) is a major pro-apoptotic factor with multifunctional activity. This review summarizes new data about the main representative of Bcl-2 family – Bax, its structure and mechanism(s) by which this protein modulates apoptosis.

Keywords

apoptosis, Bcl-2 family, Bax, apoptosis mitochondrial pathway

References

Apte, S.S., Mattei, M.G., Olsen, B.R. 1995. Mapping of the human bax gene to chromosome 19q13.3-13.4 and isolation of a novel alternatively spliced transcript Bax delta. Genomics 26: 592–594.

Bargou, R.C., Bommert, K., Weinmann, P., Daniel, P.T., Wagener, C., Mapara, M.Y., Dörken, B. 1995. Expression of the bcl-2 gene family in normal and malignant breast tissue: low bax-alpha expression in tumor cells correlates with resistance towards apoptosis. Eur. J. Immunol. 25: 770–775.

Bednarek, J., Kiliańska, Z.M. 2005. Białka przestrzeni międzybłonowej mitochondriów uczestniczące w procesie apoptozy. Post. Biochem. 51: 447–458.

Borner C. 2003. The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol. Immunol. 39: 615–647.

Breckenridge, D.G., Germain, M., Mathai, J.P., Nguyen, M., Shore, G.C. 2003. Regulation of apoptosis by endoplasmic reticulum pathway. Oncogene 22: 8608–8618.

Brustovetsky, T., Li, T., Yang, Y., Zhang, J.T., Antonsson, B., Brustovetsky, N. 2010. Bax insertion, oligomerization, and outer membrane permeabilization in brain mitochondria: Role of permeability transition and SH-redox regulation. Biochim. Biphys. Acta 1797: 1795–1806.

Cao, X., Deng, X., May, W.S. 2003. Cleavage of Bax to p18 Bax accelerates stress-induced apoptosis, and a cathepsin-like protease may rapidly degrade p18 Bax. Blood. 102: 2605–2614.

Cartron, P.F., Gallenne, T., Bugras, G., Gautier., Manero, F., Vuso, P., Meflah, K., Vallette, F.M., Juin, P. 2004. The first α-helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and Puma. Mol. Cell. 16: 807–818.

Cartron, P.F., Oliver, L., Martin, S., Moreau, C., Lecabellec, M.T., Jezequel, P., Meflah, K., Vallette, F.M. 2002. The expression of a new variant of the pro-apoptotic molecule Bax, Bax psi, is correlated with an increased survival of glioblastoma multiforme patients. Hum. Mol. Genet. 11: 675–687.

Castle, V.P., Heidelberger, K.P., Bromberg, J., Ou, X., Dole, M., Nuñez, G. 1993. Expression of the apoptosis-suppressing protein Bcl-2 in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am. J. Pathol. 143: 1543–1550.

Chipuk, J.E., Bouchier-Hayes, L., Green, D.R. 2006. Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell. Death Differ. 13: 1396–1402.

Chipuk, J.E., Green, D. 2004. Cytoplasmic p53: bax and forward. Cell Cycle. 3: 429–431.

Chipuk, J.E., Green, D. 2008. How do Bcl-2 proteins induce mitochondria outer membrane permeabilization? Trends Cell. Biol. 18: 157–164.

Christenson, E., Merlin, S., Saito, M., Schlesinger, P. 2008. Cholesterol effects on Bax pore activation. J. Mol. Biol. 381: 1168–1183.

Codogno, P., Meijer, A.J. 2006. Atg: more than autophagy factor. Nat. Cell. Biol. 8: 1045–1047.

Cornblau, S.M., Thall, P.F., Estrov, Z., Walterscheid, M., Patel, S., Theriault, A., Keating, M.J., Kantarjian, H., Estey, E., Andreeff, M. 1999. The prognostic impact of Bcl2 protein expression in acute myelogenous leukemia varies with cytogenetics. Clin. Cancer. Res. 5: 1758–1766.

Cory, S., Huang, D.C., Adams, J.M. 2003. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22: 8590–8607.

Cuddeback, S.M., Yamaguchi, H., Komatsu, K., Miyashita, T., Yamada, M., Wu, C., Singh, S., Wang, H.G. 2001. Molecular cloning and characterization of Bif-1. A novel Src homology 3 domain-containing protein that associates with Bax. J. Biol. Chem. 276: 20559–20565.

Day, C.L., Smits, C., Fan, F.C., Lee, E.F., Fairlie, W.D., Hinds, M.G. 2008. Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1. J. Mol. Biol. 380: 958–971.

Desagher, S., Osen-Sand, A., Nichols, A., Eskes, R., Montessiut, S., Lauper, S., Maundrell, K., Antonsson, B., Martinou, J.C. 1999. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 144: 891–901.

Droin, N.M., Green, D.R. 2004. Role of Bcl-2 family members in immunity and disease. Biochim. Biophys. Acta. 1644: 179–188.

Ewings, K.E., Hadfield-Moorhouse, K., Wiggins, C.M., Wickenden, J.A., Balmanno, K., Gilley, R., Degenhardt, K., White, E., Cook, S.J. 2007. ERK1/2-dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl-1 and Bcl-XL. EMBO J. 26: 2856–2867.

Falke, D., Fisher, M., Ye, D., Juliano, R.L. 2003. Design of artificial transcription factors to selectively regulate the pro-apoptotic bax gene. Nucleic Acids Res. 31(3): e10.

Ferreira, C.G., Epping, M., Kruyt, F.A.E., Giaccone, G. 2002. Apoptosis: target of cancer therapy. Clin. Cancer Res. 8: 2024–2034.

Frey, V., Viaud, J., Subra, G., Cauquil, N., Guichou, J.F., Casara, P., Grassy, G., Chavanieu, A. 2008. Structure-activity relationships of Bak derived peptides: Affinity and specificity modulations by amino acid replacement. Eur. J. Med. Chem. 43: 966–972.

Gao, G., Dou, Q.P. 2000. N-terminal cleavage of Bax by calpain generates a potent proapoptotic 18 kDa fragment that promotes bcl-2-independent cytochrome c release and apoptotic cell death. J. Cell. Biochem. 80: 53–72.

George, N.M., Targy, N., Evans, J.J., Zhang, L., Luo, X. 2010. Bax contains two functional mitochondrial targeting sequences and translocates to mitochondria in a conformational change- and homo-oligomerization-driven process. J. Biol. Chem. 285: 1384–1392.

Gotoh, T., Terada, K., Oyadomari, S., Mori, M. 2004. Hsp70-DnaJ chaperone pair prevents nitric oxide- and CHOP-induced apoptosis by inhibiting translocation of Bax to mitochondria. Cell. Death. Differ. 11: 390–402.

Greijer, A.E., van der Wall, E. 2004. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J. Clin. Pathol. 57: 1009–1014.

Griffiths, G. J., Corfe, B.M., Savory, P., Leech, S., Esposti, M.D., Hickman, J.A., Dive, C. 2001. Cellular damage signals promote sequential changes at the N-terminus and BH-1 domain of the pro-apoptotic protein Bak. Oncogene 20: 7668–7676.

Guo, B., Godzik, A., Reed, J.C. 2001. Bcl-G, a novel pro-apoptotic member of the Bcl-2 family. J. Biol. Chem. 276: 2780–2785.

Gurudutta, G.U., Verma, Y.K., Singh, V.K., Gupta, P., Raj, H.G., Sharma, R.K., Chandra, R. 2005. Structural conservation of residues in BH1 and BH2 domains of Bcl-2 family proteins. FEBS Lett. 579: 3503–3507.

Hanson, C.J., Bootman, M.D., Distelhorst, C.W., Maraldi, T., Roderick, H.L. 2008. The cellular concentration of Bcl-2 determinates its pro- or anti-apoptotic effect. Cell. Calcium 44: 243–258.

Hayashi, T., Faustman, D.L. 2003. Role of defective apoptosis in type 1 diabetes and other autoimmune diseases. Rec. Prog. Horm. Res. 58: 131–153.

Hengartner, M.O. 2000. The biochemistry of apoptosis. Nature 407: 770–776.

Hetz, C., Glimcher, L. 2008. The daily job of night killers: alternative roles of the Bcl-2 family in organelle physiology. Trends. Cell. Biol. 18: 38–44.

Hossini, A.M., Eberle, J. 2008. Apoptosis induction by Bcl-2 proteins independent of the BH3 domain. Biochem. Pharmacol. 76: 1612–1619.

Hückelhoven, R. 2004. Bax inhibitor-1, an ancient cell death suppressor in animals and plants with prokaryotic relatives. Apoptosis 9: 299–307.

Jansen, B., Schlagbauer-Wadl, H., Brown, B.D., Bryan, B.D., van Elsas, A., Müller, M., Wolff, K., Eichler, H.G., Pehamberger, H. 1998. Bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nat. Med. 4: 232–234.

Jin, K.L., Graham S.H., Mao, X.O., He, X., Nagayama, T., Simon, R.P., Greenberg, D.A. 2001. Bax kappa, a novel Bax splice variant from ischemic rat brain lacking an ART domain, promotes neuronal cell death. J. Neurochem. 77: 1508–1519.

Karst, A.M., Li, G. 2007. BH3-only proteins in tumorigenesis and malignant melanoma. Cell. Mol. Life Sci. 64: 318–330.

Kataoka, T., Holler, N., Micheau, O., Martinon, F., Tinel, A., Hofmann, K., Tschopp, J. 2001. Bcl-rambo, a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension. J. Biol. Chem. 276: 19548–19554.

Ke, N., Godzik, A., Reed, J.C. 2001. Bcl-B, a novel Bcl-2 family member that differentially binds and regulates Bax and Bak. J. Biol. Chem. 276: 12481–12484.

Khor, L.Y., Moughan, J., Al-Saleem, T., Hammond, E.H., Venkatesan, V., Rosenthal, S.A., Ritter, Ma., Sandler, H.M., Hanks, G.E., Shipley, W.U., Pollack, A. 2007. Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol 92-02. Clin. Cancer Res. 13: 3585–3590.

Kiliańska, Z.M. 2002. Apoptoza organizmów zwierzęcych. In: L. Kłyszejko-Stefanowicz (ed.) Cytobiochemia. Biochemia niektórych struktur komórkowych. Wydawnictwo Naukowe PWN, Warszawa, pp. 772–814.

Kobayashi, T., Sawa, H., Morikawa, J., Zhang, W., Shiku, H. 2000. Bax induction activates apoptotic cascade via mitochondrial cytochrome c release and Bax overexpression enhances apoptosis induced by chemotherapeutic agents in DLD-1 colon cancer cells. Jpn. J. Cancer Res. 91: 1264–1268.

Kobylinska, A., Bednarek, J., Blonski, J.Z., Hanausek, M., Walaszek, Z., Robak, T., Kilianska, Z.M., 2006. In vitro sensitivity of B-cell chronic lymphocytic leukemia to cladribine and its combinations with mafosfamide and/or mitoxantrone. Oncol. Rep. 16: 1389–1395.

Kolluri, S.K., Zhu, X., Zhou, X., Lin, B., Chen, Y., Sun, K., Tian, X., Town, J., Cao, X., Lin, F., Zhai, D., Kitada, S., Luciano, F., Donnell, E., Cao, Y., He, F., Lin, J., Reed, J.C., Satterthwait, A.C., Zhang, X.K. 2008. A short Nur77- derived peptide converts Bcl-2 from a protector to a killer. Cancer Cell. 14: 285–298.

Konopleva, M., Tari, A.M., Estrov, Z., Harris, D., Xie, Z., Zhao, S., López-Berestein, G., Andreeff, M. 2000. Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins. Blood 95: 3929–3938.

Krajewski, S., Krajewska, M., Ellerby, L.M., Welsh, K., Xie, Z., Deveraux, Q.L., Salvesen, G.S., Bredesen, D.E., Rosenthal, R.E., Fiskum, G., Reed, J.C. 1999. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 96: 5752–5757.

Kumarswamy, R., Chandna, S. 2009. Putative partners in Bax mediated cytochrome-c release: ANT, CypD, VDAC or none of them? Mitochondrion 9: 1–8.

Leber, B., Lin, J., Andrews, D.W. 2007. Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes. Apoptosis. 12: 897–911.

Lee, R.M., Chen, J., Matthews, C.P., Mcdougall, J.K., Neiman, P.E. 2001. Characterization of NR13-related human cel death regulator, Boo/Diva, in normal and cancer tissues. Biochim. Biophys. Acta 1520: 187–194.

Li, X., Marani, M., Yu, J., Nan, B., Roth, J.A., Kagawa, S., Fang, B., Denner, L., Marcelli, M. 2001. Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer. Cancer Res. 61: 186–191.

Lin, B., Kolluri, S.K., Lin, F., Liu, W., Han, Y.H., Cao, X., Dawson, M.I., Reed, J.C., Zhang, X.K. 2004. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell 116: 527–540.

Lowe, S.W., Cepero, E., Evan, G. 2004. Intrinsic tumour suppression. Nature 432: 307–315.

Luciano, F., Krajewska, M., Ortiz-Rubio, P., Krajewski, S., Zhai, D., Faustin, B., Bruey, J.M., Bailly-Maitre, B., Lichtenstein, A., Kolluri, S.K., Satterthwait, A.C., Zhang, X.K., Reed, J.C. 2007. Nur77 converts phenotype of Bcl-B, an antiapoptotic protein expressed in plasma cells and myeloma. Blood. 109: 3849–3855.

Lucken-Ardjomande, S., Martinou, J.C. 2005. Regulation of Bcl-2 proteins and of the permeability of the outer mitochondrial membrane, Regulation of Bcl-2 proteins and of the permeability of the outer mitochondrial membrane. C. R. Biol. 328: 616–631.

Luo, X., Budihardjo, J., Zou, H., Slaughter, C., Wang, X. 1998. Bid, an Bcl-2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481–490.

Majewski, N., Nogueira, V., Bhaskar, P., Coy, P.E., Skeen, J.E., Gottlob, K., Chandel, N.S., Thompson, C.B., Robey, R.B., Hay. N. 2004. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol. Cell. 16: 819–830.

Meir, O., Dvash, E., Werman, A., Rubinstein, M. 2010. C/EBP-beta regulates endoplasmic reticulum stress-triggered cel death in mouse human models. PLOS One 5: e9516.

Ming, L., Wang, P., Bank, A., Zhang, L. 2006. PUMA dissociates Bax and Bcl-XL to induce apoptosis in colon cancer cells. J. Biol. Chem. 281: 16034–16042.

Moldoveanu, T., Liu, Q., Tocilj, A., Watson, M., Shore, G., Gehring, K. 2006. The X-ray structure of Bak homodimer reveals an inhibitory zinc binding site. Mol. Cell. 24: 677–688.

Ndozangue-Touriguine, O., Hamelin, J., Bréard, J. 2008. Cytoskeleton and apoptosis. Biochem. Pharmacol. 76: 11–18.

Oltvai, Z., Korsmeyer, S. 1993. Bcl-2 heterodimrizes in vivo with conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609–619.

Ouyang, H., Furukawa, T., Abe, T., Kato, Y., Horii, A. 1998. The BAX gene, the promoter of apoptosis, is mutated in genetically unstable cancers of the colorectum, stomach, and endometrium. Clin. Cancer. Res. 4: 1071–1074.

Pepper, C., Hoy, T., Bentley, D.P. 1997. Bcl-2/Bax ratios in chronic lymphocytic leukemia and their correlation with in vitro apoptosis and clinical resistance. Br. J. Cancer 76: 935–958.

Perez, G.I., Knudson, C.M., Leykin, L., Korsmeyer, S.J., Tilly, J.L. 1997. Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction. Nat. Med. 3: 1228–1332.

Petros, A.M., Olejniczak, E.T., Fesik, S.W. 2004. Structural biology of the Bcl-2 family of proteins. Biochim. Biophys. Acta 1644: 83–94.

Pirocanac, E.C., Nassirpour, R., Yang, M., Wang, J., Nardin, S.R., Gu, J., Fang, B., Moossa, A.R., Hoffman, R.M., Bouvet, M. 2002. Bax-induction gene therapy of pancreatic cancer. J. Surg. Res. 106: 346–351.

Rampino, N., Yamamoto, H., Ionov, Y., Li., Y., Sawai., H., Reed, J.C., Perucho, M. 1997. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275: 967–969.

Reed, J.C. 1999. Dysregulation of apoptosis in cancer. J. Clin. Oncol. 17: 2941–2953.

Reed, J.C. 2008. Bcl-2 family proteins and hematologic malignancies: history and future prospects. Blood. 111: 3322–3330.

Rodolfo C., Piacentini M. 2002. Does cytoskeleton `Akt' in apoptosis? Cell. Death Differ. 9: 477–478.

Rogalińska, M., Błoński, J.Z., Komina, O., Góralski, P., Żołnierczyk, J.D., Piekarski, H., Robak, T., Kiliańska, Z.M., Wesierska-Gadek, J. 2010. R-roscovitine (Seliciclib) affects CLL cells more strongly than combinations of fludarabine or cladribine with cyclophosphamide: Inhibition of CDK7 sensitizes leukemic cells to caspase-dependent apoptosis. J. Cell. Biochem. 76: 11–18.

Savaraj, N., You, M., Wu, C., Wangpaichitr, M., Kuo, M.T., Feun, L.G. 2010. Arginine deprivation, autophagy, apoptosis (AAA) for the treatment of melanoma. Curr. Mol. Med. 10: 405–412.

Schinzel, A., Kaufmann, T., Borner, C. 2004a. Bcl-2 family members: integrators of survival and death signals in physiology and pathology [corrected]. Biochim. Biophys. Acta. 1644: 95–105.

Schinzel, A., Kaufmann ,T., Schuler, M., Martinalbo, J., Grubb, D., Borner, C. 2004b. Conformational control of Bax localization and apoptotic activity by Pro168. J. Cell. Biol. 164: 1021–1032.

Schlesinger, P.H., Saito, M. 2006. The Bax pore in liposomes. Biophysics. Cell. Death Differ.13: 1403–1408.

Schröder, M. 2008. Endoplasmic reticulum stress responses. Cell. Mol. Life Sci. 65: 862–894.

Seo, E., Kim, S., Jho, E.H. 2009. Induction of cancer cell-specific death via MMP2 promoter-dependent Bax expression. B. M. B. Rep. 42: 217–222.

Shan, Y.X., Liu, T.J., Su, H.F., Samsamshariat, A., Mestril, R., Wang, P.H. 2003. Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells. J. Mol. Cell. Cardiol. 35: 1135–1143.

Sharpe, J.C., Arnoult, D., Youle, R.J. 2004. Control of mitochondrial permeability by Bcl-2 family members. Biochem. Biophys. Acta 1644: 107–113.

Skommer, J., Wlodkowic, D., Deptala, A. 2007. Larger than life: mitochondria and the Bcl-2 family. Leuk. Res. 31: 277–286.

Suzuki, M., Youle, R.J., Tjandra, N. 2000. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 103: 645–654.

Takahashi, Y., Karbowski, M., Yamaguchi, H., Kazi, A., Wu, J., Sebti, S.M., Youle, R.J., Wang, H.G. 2005. Loss of Bif-1 suppresses Bax/Bak conformational change and mitochondria apoptosis. Mol. Cell. Biol. 25: 9369–9382.

Terrones, O., Antonsson, B., Yamaguchi, H., Wang, H.G., Liu, J., Lee, R.M., Herrmann, A., Basañez, G. 2004. Lipidic pore formation by the concerted action of proapoptotic Bax and tBid. J. Biol. Chem. 279: 30081–30091.

Wagener, C., Bargou, C., Daniel, P.T., Bommert, K., Mapara, M.Y., Royer, H.D., Dörken, B. 1996. Induction of the death-promoting gene bax-α sensitizes cultured breast-cancer cells to drug-induced apoptosis. Int. J. Cancer 67: 138–141.

Warr, M.R., Shore, G.C. 2008. Small-molecule Bcl-2 antagonists as targeted therapy in oncology. Curr. Oncol. 15: 256–261.

Wei, M.C., Lindsten, T., Mootha V.K, Weiler, S., Gross, A., Ashiya, M., Thompson, C.B., Korsmeyer, S.J., 2000. tBid, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14: 2060–2071.

Wyllie, A.H. 2010. “Where, o death, is thy sting?” A brief review of apoptosis biology. Mol. Neurobiol. 42: 4–10.

Xu, Q., Reed, J.C., 1998, Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol. Cell. 1: 337–346.

Yan, N., Shi, Y. 2003. Histone H1.2 as a trigger for apoptosis. Nat. Struct. Biol. 10: 983–985.

Yedavalli, V.S., Shih, H.M., Chiang, Y.P., Lu, C.Y., Chang, L.Y., Chen, M.Y., Chuang, C.Y., Dayton, A.I., Jeang, K.T., Huang, L.M. 2005. Human immunodeficiency virus type 1 Vpr interacts with antiapoptotic mitochondrial protein HAX1, J. Virol. 79: 13735–13746.

Yousefi, S., Perozzo R., Schmid, I., Ziemiecki, A., Schaffner, T., Scapozza, L., Brunner, T., Simon, H.U. 2006. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat. Cell. Biol. 8: 1124–1132.

Zamzami, N., Hamel, E., Maisse, C., Brenner, C., Muñoz-Pinedo, C., Balzacq, A.S., Costantini, P., Vieira, H., Loeffler, M., Molle, G., Kroemer, G. 2000. Bid acts on the permeability transition pore complex to induce apoptosis. Oncogene 19: 6342–6350.

Zhai, D., Luciano, F., Zhu, X., Guo, B., Satterthwait, A.C., Reed, J.C. 2005. Humanin binds and nullifies Bid activity by blocking its activation of Bax and Bak. J. Biol. Chem. 280: 15815–15824.

Żołnierczyk, J.D., Błoński, J.Z., Robak, T., Kiliańska, Z.M., Wesierska-Gadek, J. 2009. Roscovitine triggers apoptosis in B-cell chronic lymphocytic leukemia cells with similar efficiency as combinations of conventional purine analogs with cyclophosphamide. Ann. N.Y. Acad. Sci. 1171: 124–131.

First Page

5

Last Page

32

Language

eng

Share

COinS